2m 2m 2m 2m 2m 2m 2m
NEUROGENE (NGNE)
NASDAQ
$24.30-$1.78 (-6.83%)
Price as of Oct 22, 2026 7:30 PM EDT- $521.9MMarket Cap
- -15.16%1-Year Change
- BiotechnologyIndustry
NEUROGENE (NGNE)
$24.30-$1.78 (-6.83%)
NGNE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $26.08 | ||
Change | +$0.68 (+2.68%) | ||
Open | $25.52 | ||
High | $26.94 | ||
Low | $25.11 | ||
Previous Close | $25.40 | ||
Volume | 588,807 | ||
30-Day Average Volume | 368,085 | ||
1-Week Change | 17.58% | ||
1-Month Change | -19.93% | ||
1-Year Change | -15.16% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 20.0M | ||
Total Assets | $244.4M | ||
Market Cap | $521.9M | ||
Enterprise Value | $409.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$34.5M | ||
Free Cash Flow | -$24.1M | ||
EBIT | -$34.5M | ||
EBITDA | -$33.7M | ||
Net Working Capital | $207.4M | ||
EPS | -$1.53 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -17 | ||
PEG | 2 | ||
Price/Free Cash Flow | -22 | ||
Price/Operating Cash Flow | -22 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 09/25/2023 | ||
Earnings & Revenue